Chimin(SH:603222) Xin Lang Cai Jing·2025-11-21 01:29Group 1 - The core viewpoint of the news is that Jimin Health experienced a decline in stock price and significant changes in financing activities, indicating potential liquidity issues and a challenging financial environment [1][2]. Group 2 - On November 20, Jimin Health's stock fell by 1.76%, with a trading volume of 218 million yuan. The financing data showed a net financing outflow of 3.41 million yuan for the day, with a total financing and securities balance of 225 million yuan [1]. - The financing buy-in for Jimin Health on that day was 11.61 million yuan, while the current financing balance is 224 million yuan, accounting for 4.26% of the circulating market value, which is above the 60th percentile level over the past year [1]. - In terms of securities lending, there were no shares repaid or sold on November 20, with a remaining short position of 9,000 shares and a short balance of 90,400 yuan, exceeding the 90th percentile level over the past year [1]. Group 3 - As of September 30, Jimin Health had 58,100 shareholders, an increase of 107% compared to the previous period, while the average circulating shares per person decreased by 51.69% to 9,035 shares [2]. - For the period from January to September 2025, Jimin Health reported a revenue of 545 million yuan, a year-on-year decrease of 20.21%, and a net profit attributable to shareholders of -77.15 million yuan, a year-on-year decrease of 371.51% [2]. Group 4 - Since its A-share listing, Jimin Health has distributed a total of 127 million yuan in dividends, with 10.74 million yuan distributed over the past three years [3].